Indications for use of anti-GM1 Autoantibodies ELISA
Anti-GM1 Antibodies: anti-GM1 antibodies (IgG) are implicated in the pathogenesis of Guillain-Barré Syndrome (GBS) and anti-GM1 antibodies (IgM) in multifocal neuropathy (MMN) and lower motor neuron disease (LMND). Anti-GM1 autoantibodies (IgM) may be present as monoclonal IgM paraprotein or as a polyclonal IgM. Polyclonal IgG may be detected in patients with motor neuropathies. High GM1 antibody titers may be detected in association with in Guillain-Barré Syndrome (GBS) following Campylobacter jejuni
infection. GM1 is the most relevant target antigen in neural tissue. The fact that GM1 is the only common glycolipid antigen reactive with all of the GM1 antibodies found in motor nerve disorders underlines its importance in immune-mediated peripheral neuropathies.
anti-GM1 Autoantibodies ELISA Product Information
|Time to Result
||4.5 h (approx.)
||20 µl serum (1:50)
||IgG and IgM